Over the last 7 days, the United States market has experienced a 1.6% drop, yet it remains up by 12% over the past year with projected earnings growth of 17% per annum in the coming years. In such a fluctuating environment, companies with high insider ownership like Astrana Health can be appealing as they often indicate strong internal confidence and alignment between management and shareholder interests.
Top 10 Growth Companies With High Insider Ownership In The United States
| Name | Insider Ownership | Earnings Growth |
| Upstart Holdings (UPST) | 14.0% | 70.2% |
| Standard Nuclear (STDN) | 18.8% | 64.2% |
| Sable Offshore (SOC) | 11.3% | 76% |
| Precigen (PGEN) | 11.7% | 54% |
| Nu Holdings (NU) | 22.8% | 22.3% |
| Karman Holdings (KRMN) | 13.6% | 56.4% |
| Himax Technologies (HIMX) | 29.1% | 70.2% |
| Figure Technology Solutions (FIGR) | 21.4% | 32.4% |
| Energy Vault Holdings (NRGV) | 10.5% | 67.3% |
| Almonty Industries (ALM) | 10.8% | 57.2% |
We're going to check out a few of the best picks from our screener tool.
Astrana Health (ASTH)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Astrana Health, Inc. is a healthcare management company offering medical care services in the United States with a market cap of approximately $1.94 billion.
Operations: The company's revenue segments include Care Delivery at $338.73 million, Care Partners at $3.63 billion, and Care Enablement at $339.54 million.
Insider Ownership: 10.7%
Earnings Growth Forecast: 29.0% p.a.
Astrana Health's earnings are expected to grow significantly, outpacing the US market. Despite slower revenue growth at 8.4% annually, its earnings surged by 60.5% last year and are forecast to continue growing robustly. The company trades well below its estimated fair value and is actively seeking strategic acquisitions to enhance growth prospects. Recent buybacks indicate strong cash flow management, although interest payments remain a concern for financial stability.
- Get an in-depth perspective on Astrana Health's performance by reading our analyst estimates report here.
- In light of our recent valuation report, it seems possible that Astrana Health is trading behind its estimated value.
Live Oak Bancshares (LOB)
Simply Wall St Growth Rating: ★★★★★☆
Overview: Live Oak Bancshares, Inc. is the bank holding company for Live Oak Banking Company, offering a range of banking products and services in the United States with a market cap of $1.61 billion.
Operations: The company's revenue is primarily generated from its banking platform for small businesses, amounting to $526.38 million.
Insider Ownership: 22.1%
Earnings Growth Forecast: 29.1% p.a.
Live Oak Bancshares is poised for significant growth, with earnings expected to increase by 29.1% annually, surpassing the US market's average. Despite a high bad loans ratio of 4.2%, the company trades at 50% below its estimated fair value and analysts predict a potential price rise of 21.3%. Recent earnings reports show substantial improvements, with net income reaching US$36.8 million in Q2 2026 from US$23.43 million last year, reflecting robust financial health amidst insider selling concerns.
- Unlock comprehensive insights into our analysis of Live Oak Bancshares stock in this growth report.
- Our comprehensive valuation report raises the possibility that Live Oak Bancshares is priced lower than what may be justified by its financials.
Sea (SE)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Sea Limited is a technology company operating through its subsidiaries in Southeast Asia, Latin America, and other international markets with a market cap of $58.76 billion.
Operations: Sea Limited generates revenue through its digital entertainment segment ($3.25 billion), e-commerce operations ($7.48 billion), and digital financial services ($1.09 billion).
Insider Ownership: 14.0%
Earnings Growth Forecast: 24.9% p.a.
Sea Limited demonstrates potential as a growth company with high insider ownership, despite recent significant insider selling. The company reported strong earnings growth of 37% over the past year and expects annual profit growth of 24.9%, outpacing the US market average. Revenue is forecast to grow at 16.2% annually, above the market rate but below 20%. Trading at a substantial discount to fair value, analysts anticipate a price increase of 62.6%.
- Take a closer look at Sea's potential here in our earnings growth report.
- Upon reviewing our latest valuation report, Sea's share price might be too pessimistic.
Taking Advantage
- Discover the full array of 188 Fast Growing US Companies With High Insider Ownership right here.
- Ready For A Different Approach? We've found 7 US stocks that are forecast to pay a dividend yeild of over 6% next year. See the full list for free.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com